Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Owing to the impact of COVID-19, the study had to be withdrawn.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Westlake Gut Microbiome study is a prospective cohort study. This project aims to characterize the gut microbiome among Chinese populations from different regions of China, and explore the relationships between gut microbiota and human health. Human fecal samples will be collected from the participants and muli-omics detection and analysis will be performed.
In the first phase of the study (also a pilot study), the investigators will create a longitudinal datasets from a students-based cohort in Westlake University. Information about demography, life style, diet, medical history, physical activity will be recorded, clinical examinations such as blood glucose, body composition and electroencephalogram will be examined, and biological samples including blood, saliva, urine and feces, will be collected.
In the second phase, the investigators will expand to include eligible participants from at least 10 provinces of China, which are located at different regions. Similar to the procedures in phase 1 stage, information about demography, life style, diet, medical history, physical activity will be recorded, clinical examinations will be performed, and biological samples will be collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Gut microbiota | Fecal microbiome will be analyzed by 16S rRNA gene sequencing and metagenome sequencing. | 36 months |
| Metabolomics of serum and gut microbiome | Metabolomics of serum and gut microbiome will be analyzed by liquid chromatograph-mass spectrometer (LC/MS) | 36 months |
| Proteomic profiling of serum | Proteomic characterization of serum will be analyzed by liquid chromatograph-mass spectrometer (LC/MS) | 36 months |
| Measure | Description | Time Frame |
|---|---|---|
| Body composition | Body composition will be analyzed using composition automatic analyzer at the time point of sample collection by compostion automatic analyzer. | 36 months |
| Biochemical examination of blood samples |
Not provided
Inclusion Criteria:
Participants or her/his legal guardian are able to report the antibiotics use during the past 3 months; Participants or her/his legal guardian are able to understand and respond to the online questionairs; Participants or her/his legal guardian are able and willing to collect the biological samples as instructed; Participants or her/his legal guardian are able and willing to provide written informed consent; -
Exclusion Criteria:
Those with serious fundamental diseases or infectious diseases; and those with other conditions that not suitable to participate in this study, as considered by the investigators.
-
Not provided
Not provided
All the participants should be Chinese residents, regardless of the ethics.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ju-Sheng Zheng, PhD | Westlake University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Westlake University | Hangzhou | Zhejiang | 310024 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
venous blood, saliva, urine and feces.
Blood glucose, blood lipids, serum cytokines will be examined.
| 36 months |